Codes / ICD10CM / T42.2X

T42.2X Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones
ICD-10 Code: T42.2X

Summary

This code encompasses conditions related to succinimides and oxazolidinediones, including poisoning, adverse effects, and underdosing. It applies to clinical scenarios where these medications cause harm, unintended reactions, or insufficient therapeutic levels. The classification depends on the nature of the drug interaction and clinical presentation.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose, drug interactions, or incorrect administration. Underdosing occurs due to subtherapeutic dosing, patient non-compliance, or pharmacokinetic factors like altered metabolism. Adverse effects can stem from idiosyncratic reactions or prolonged use.

Risk Factors

  • Polypharmacy increasing drug interaction risks.
  • History of conditions treated with succinimides or oxazolidinediones.
  • Age-related changes affecting drug metabolism or compliance.
  • Limited supervision or access to medications.

Symptoms

  • Poisoning: Drowsiness, respiratory depression, confusion, or seizures.
  • Adverse effects: Nausea, dizziness, or muscle weakness.
  • Underdosing: Recurrence of underlying condition symptoms.

Diagnosis

Diagnosis involves clinical evaluation, medication history, and laboratory tests to confirm exposure or therapeutic failure. Documentation should specify the clinical context (e.g., poisoning, adverse effect, or underdosing) and any contributing factors.

Treatment Options

Treatment depends on the clinical scenario. For poisoning, supportive care and decontamination may be necessary. Adverse effects may require dose adjustment or discontinuation. Underdosing is managed by optimizing therapeutic levels through dose modification or addressing compliance issues.

Prognosis and Follow-Up

Prognosis varies based on the severity of exposure or effect. Follow-up includes monitoring for resolution of symptoms, therapeutic drug levels, and potential long-term effects. Regular assessments help prevent recurrence or complications.

Complications

Complications may include organ toxicity, persistent neurological effects, or worsening of the underlying condition due to underdosing. Severe poisoning can lead to respiratory failure or seizures.

Lifestyle & Prevention

Prevention focuses on proper medication storage, education on dosing, and avoiding drug interactions. Patients should be counseled on adherence and recognizing early signs of adverse effects or underdosing.

When to Seek Professional Help

Seek immediate care for suspected poisoning (e.g., confusion, respiratory distress) or if adverse effects worsen. Consult a provider for recurrent symptoms indicating underdosing or unmanaged side effects.

Tips for Medical Coders

Document the clinical context (poisoning, adverse effect, or underdosing) and any contributing factors. Ensure specificity in the encounter type (e.g., initial, subsequent) and note if the code is for a sequela. Verify the drug class aligns with succinimides or oxazolidinediones to support accurate coding.

Book a walkthrough

T42.2X policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.